Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Front Chem ; 12: 1365880, 2024.
Article in English | MEDLINE | ID: mdl-38532806

ABSTRACT

A key challenge for the effective treatment of intestinal diseases, including inflammatory bowel disease (IBD), is to develop an oral drug delivery system that can resist gastric acid erosion and efficiently release drugs after rapid entry into the intestine. In the present work, we developed oral composite nanoparticles (MSZ@PRHS) consisting of a rough mesoporous silica (RHS) loaded with Mesalazine (MSZ) and a CAP polymer membrane for targeted relief of inflammation in colitis. At the pH values of the simulated stomach and small intestine, the release rate of MSZ from MSZ@PRHS was low, while at the pH values of the simulated colon, the release rate of MSZ was high. In dextran sulfate sodium salt (DSS)-induced acute colitis mouse model, compared with oral administration of the drug Mesalazine in the equivalent solution form, oral administration of PRHS loaded with drug-loaded nanoparticles can significantly alleviate the symptoms of inflammatory bowel disease, and improve the therapeutic effect. We propose that the intestinal microenvironment provides an interface for nanocomposites switch and a promising drug delivery platform for the management and treatment of many intestinal diseases, where controlled drug release and prolonged residence time are required.

2.
Materials (Basel) ; 16(14)2023 Jul 20.
Article in English | MEDLINE | ID: mdl-37512383

ABSTRACT

This paper presents results on the microstructure and mechanical properties of a new low-cost titanium alloy Ti-5Al-1.5Mo-1.8Fe after different forging processes. The ß phase transformation temperature of this alloy was 950 °C. In this study, the forging temperatures were designed at 920 °C and 980 °C, and the deformation degree ranged from 20% to 60%, with an interval of 20%. This study investigated the impact of the equiaxed α phase and shape of the lamellar microstructure on the tensile characteristics and fracture toughness of an alloy. The research employed a microstructure analysis and static tensile testing to evaluate the effect of forging temperatures and degree of deformation on the microstructure features. The findings revealed that forging temperatures could modify the microstructure characteristics, and the degree of deformation also affected this microstructure. This study demonstrates that a bimodal structure with an equiaxed α phase can be utilized to balance high strength and high ductility, resulting in better overall mechanical properties.

3.
J Cancer Res Ther ; 17(5): 1202-1208, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34850768

ABSTRACT

AIM OF STUDY: The conclusions on the association between the rs2736100 polymorphisms of telomerase reverse transcriptase (TERT) gene polymorphism and digestive cancers risk are still debated. This meta-analysis was conducted to update the association between the TERT rs2736100 polymorphisms and the risk of digestive cancers. MATERIALS AND METHODS: The association investigations were identified from PubMed and Cochrane Library, and eligible studies were included and synthesized using the meta-analysis method. RESULTS: Eight case-control studies were included in this meta-analysis for associating TERT rs2736100 gene polymorphism and digestive cancer susceptibility. Pooled odds ratio with 95% confidence interval was calculated using a fixed or random-effects model. Overall, no evidence has shown that the TERT rs2736100 polymorphism was associated with the susceptibility to digestive cancers. Besides, stratified analysis with ethnicity also indicated no significant association between TRET rs2736100 and the risk of digestive cancers under all genetic models in both Asian and Caucasian populations were observed. CONCLUSION: According to the meta-analysis, TERT rs2736100 polymorphism might be unrelated to digestive cancer susceptibility. Evidence with adequate sample size is still needed.


Subject(s)
Biomarkers, Tumor/genetics , Digestive System Neoplasms/pathology , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Telomerase/genetics , Case-Control Studies , Digestive System Neoplasms/genetics , Humans , Prognosis , Risk Factors
4.
Phytother Res ; 34(12): 3388-3399, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32901987

ABSTRACT

Although thymoquinone (TQ) has been reported to exert antitumor activity against various types of human cancers without evident toxicity, limited studies have reported the effects of TQ on esophageal cancer. Here, we showed that TQ induced cell cycle arrest in the G2/M phase and significantly inhibited cell proliferation and invasion. Further investigation of the potential mechanism revealed that TQ increased the levels of p53 and p21 but significantly reduced the expression of Cyclin B1, Cyclin A, and Cyclin E. Moreover, TQ led to a decrease in Bcl-2 and an increase in cleaved caspase-3, cleaved caspase-7, cleaved caspase-9, and Bax, indicating that TQ induced apoptosis by activating the intrinsic mitochondrial apoptosis pathway. Western blotting showed that TQ disrupted the PI3K/AKT pathway by upregulating PTEN, thus modulating GSK-3ß activity, increasing ß-catenin degradation, and decreasing decreased MMP-2 and MMP-9 levels in Eca109 cells. However, these changes were attenuated by disrupting PTEN function (using a potent inhibitor) or downregulating PTEN expression. In addition, in vivo results showed that the efficacy of TQ as an antitumor agent in a mouse xenograft tumor model. In conclusion, TQ suppressed human esophageal cancer cells proliferation and invasion both in vitro and in vivo and could provide a novel therapeutic approach for esophageal cancer.


Subject(s)
Benzoquinones/therapeutic use , Cell Proliferation/drug effects , Esophageal Neoplasms/drug therapy , PTEN Phosphohydrolase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Wnt Signaling Pathway/drug effects , Animals , Benzoquinones/pharmacology , Cell Line, Tumor , Esophageal Neoplasms/pathology , Glycogen Synthase Kinase 3 beta/metabolism , Humans , Male , Mice , Mice, Nude , Phosphatidylinositol 3-Kinases/metabolism , Transfection , Up-Regulation , Xenograft Model Antitumor Assays
5.
Appl Opt ; 59(8): 2416-2421, 2020 Mar 10.
Article in English | MEDLINE | ID: mdl-32225776

ABSTRACT

Laser engraving technology is a type of laser processing technology, widely used for product coding, marking, and so on. A large amount of research has reported the results of metal surface engraving; however, few research results, to the best of our knowledge, have provided theoretical support for the application of paper packaging laser engraving. In this paper, the quality of paper laser engraving is investigated by experimental methods. First, various phenomena appearing in paper carving were studied, including plant fiber burning, charcoal, and edge marks; second, the main factors affecting the quality of laser engraving are researched, and the influence of laser intensity and the preset width of carving marks on the engraving quality are discussed. The results show that the engraving precision is the best when the laser power is 11 W and the preset width is small (0.26 mm). Finally, the laser engraving precision of UV coated paper is studied, and the effect of UV material melting and secondary crystallization on engraving the quality of paper laser engraving quality is discussed. When the laser power is small, the maximum and minimum values of UV film melting and secondary crystallization engraving trace are relatively small as well; further, when the laser power increases, the maximum width of engraving is basically consistent with the preset width, and the precision of laser engraving is optimal.

6.
Life Sci ; 250: 117553, 2020 Jun 01.
Article in English | MEDLINE | ID: mdl-32194081

ABSTRACT

AIMS: Enhancer of zeste homolog 2 (EZH2) is associated with ulcerative colitis development. However, the mechanism of EZH2 in ulcerative colitis progression remains unclear. MAIN METHODS: Lipopolysaccharide (LPS)-treated Caco-2 cells and dextran sodium sulfate (DSS)-treated mice were used as model of ulcerative colitis. The levels of EZH2, angiopoietin-like 4 (ANGPTL4) and cyclic adenosine monophosphate response element-binding protein 1 (CREB1) were tested via quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. Cell viability and apoptosis was measured via 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide or flow cytometry. The abundances of inflammatory cytokines were examined via qRT-PCR and enzyme-linked immunosorbent assay. The association between EZH2 and ANGPTL4 was explored via chromatin immunoprecipitation. The colon damage in DSS-treated mice was investigated by colon length, histological analysis, inflammatory response and apoptosis. KEY FINDINGS: LPS induced viability inhibition, inflammatory response and apoptosis in Caco-2 cells. EZH2 expression was increased but ANGPTL4 and CREB1 levels were decreased in LPS-challenged Caco-2 cells. Overexpression of ANGPTL4 or CREB1 suppressed LPS-induced damage in Caco-2 cells. EZH2 could target ANGPTL4 to mediate CREB1 expression. Inhibition of EZH2 suppressed LPS-caused injury. Moreover, knockdown of ANNGPTL4 or CREB1 attenuated the role of EZH2 inhibition. DSS caused the reduced colon length and increased inflammatory response as well as apoptosis. EZH2 expression was up-regulated but ANGPTL4 and CREB1 expression were down-regulated in DSS-treated mice. SIGNIFICANCE: Inhibition of EZH2 declined LPS-induced injury in Caco-2 cells by mediating ANGPTL4 and CREB1, indicating the potential of EZH2 in treatment of ulcerative colitis.


Subject(s)
Angiopoietin-Like Protein 4/metabolism , Colitis, Ulcerative/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Enhancer of Zeste Homolog 2 Protein/antagonists & inhibitors , Animals , Apoptosis , Caco-2 Cells , Cell Survival , Disease Progression , Humans , Inflammation , Lipopolysaccharides , Male , Mice , Mice, Inbred BALB C
7.
Materials (Basel) ; 11(9)2018 Sep 03.
Article in English | MEDLINE | ID: mdl-30177662

ABSTRACT

The Arrhenius-type constitutive equation is mostly used to describe flow behaviors of material. However, no processing map has been constructed directly according to it. In this study, a novel computational method was applied for establishing the processing map for Ti-6Al-4V alloy in the temperature and strain rate range of 800⁻1050 °C and 0.001⁻10 s-1, respectively. The processing map can be divided into four domains according to its graphic features. Among the four domains, the optimal domain is in the temperature and strain rate range of 850⁻925 °C and 0.001⁻0.1 s-1, where peak efficiency η is 0.54 and the main microstructural evolution is DRX (dynamic recrystallization). When the alloy is processed in the α + ß phase field, the temperature and strain rate range of 800⁻850 °C and 3⁻10 s-1 should be avoided, where instability parameter ξ is negative and the microstructural feature is flow localization. When the alloy is processed in the ß phase field, DRV (dynamic recovery) and slight DRX of ß phase is the main microstructural characteristics in the range of 1000⁻1050 °C and 0.001⁻0.02 s-1. However, flow localization of ß phase is the main microstructural feature in the range of 1000⁻1050 °C and 1⁻10 s-1, which should be avoided.

8.
J Cell Biochem ; 119(7): 5233-5242, 2018 07.
Article in English | MEDLINE | ID: mdl-29236306

ABSTRACT

The objective of this study was to explore the role of rs4705342 located in the miR-143 promoter in relation to the control of HBV positive HCC and the underlying molecular mechanism. A luciferase assay was performed to explore the factors which influenced miR-143 transcription activity and the target gene of miR-143. This would further be confirmed by ChIP assay. Western blot and real-time PCR were performed to identify the relationship between miR-143 and ORP8. Luciferase activity of miR-143 SNP was increased with the presence of C allele. The presence of T allele partially restored the transcription ability. NF-κB displayed a much higher degree of luciferase activity in relation to the cells transfected with vectors containing either T or C allele rather than control cells with a greater extent in C allele group than T allele group. At the same time, ChIP assay indicated that the affinity of NF-ΚB in the miR-143 promoter was higher in C/C cells. The over-expression of HBX promotes NF-kB expression thus increasing the extent of binding of NF-kB on the CC allele of the miR-143 promoter. The binding is also abolished by NF-kB siRNA. ORP8 was proven to be a target gene of miR-143 using bioinformatics algorithm analysis. It was further confirmed by the luciferase assay that miR-143 substantially inhibited luciferase activities of wild-type ORP8. However, it did not affect the mutant ORP8. HBx induced by HBV infection up-regulated miR-143 expression. NF- kB can partially abolish the promotion effect of HBx on the miR-143 level in cells genotyped as CC but not in cells genotyped as TT. Tissues derived from participants genotyped as CC exhibited a higher level of miR-143, but a lower level of ORP8. The presence of the minor allele of rs4705342 in the promoter of miR-143 attenuated the transcription ability. This promoted ORP8 expression and could be a factor contributing to the oncogenesis in HBV positive HCC.


Subject(s)
Hepatitis B virus/pathogenicity , Liver Neoplasms/genetics , MicroRNAs/metabolism , NF-kappa B/metabolism , Polymorphism, Genetic/genetics , Blotting, Western , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Chromatin Immunoprecipitation , Genotype , Humans , Immunohistochemistry , MicroRNAs/genetics , Promoter Regions, Genetic/genetics , Receptors, Steroid/genetics , Receptors, Steroid/metabolism
9.
Medicine (Baltimore) ; 96(50): e9267, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29390375

ABSTRACT

RATIONALE: Esophageal variceal bleeding caused by portal hypertension is massive and life-threatening to those patients with decompensated liver cirrhosis. A transjugular intrahepatic portosystemic shunt (TIPS) can effectively stop bleeding. But the process of puncture may lead to bile duct injury and even form fistulas between the hepatic artery and bile duct. PATIENT CONCERNS: The case report illustrated a 52-year-old Chinese female patient who underwent TIPS. DIAGNOSES: She suffered from acute upper gastrointestinal hemorrhage and acute pancreatitis because of the bile duct injury after TIPS. INTERVENTIONS: The fistulas between the hepatic artery and bile duct was embolized. OUTCOMES: The acute upper gastrointestinal hemorrhage and acute pancreatitis of the patient were cured. LESSONS: The arteriobiliary fistula should be paid more attention after TIPS while early-stage prevention should be carried out.


Subject(s)
Embolization, Therapeutic/methods , Hemobilia/therapy , Hepatic Artery , Pancreatitis/therapy , Portasystemic Shunt, Transjugular Intrahepatic/adverse effects , Vascular Fistula/therapy , Acute Disease , Female , Hemobilia/etiology , Humans , Middle Aged , Pancreatitis/etiology , Vascular Fistula/etiology
10.
Neurosci Lett ; 630: 158-163, 2016 Sep 06.
Article in English | MEDLINE | ID: mdl-27481627

ABSTRACT

Piezo2 is an important mechano-gated ion channel that is involved in light touch sensitivity and inflammatory allodynia. However, current research has focused on the function of Piezo2 in somatic sensation but not in visceral sensation. The present study aimed to investigate the role of Piezo2 in visceral sensation of mechanically innocuous and noxious stimuli under physiological and hyperalgesic conditions using rats as a model organism. Neonatal enema with acetic acid induced visceral hypersensitivity. Intrathecal administration of Piezo2-short hairpin RNA (shRNA) reduced Piezo2 expression in lumbosacral dorsal root ganglia (DRG) at both the mRNA and protein levels. Piezo2 knock-down in DRG attenuated visceral sensation to innocuous stimuli in control rats and to both innocuous and noxious stimuli in rats with neonatal irritation. Compared with control rats, Piezo2 was not up-regulated in irritated rats at the mRNA or protein levels in thoracolumbar or lumbosacral DRGs, while TRPV1 was up-regulated in lumbosacral DRGs. These data suggest a potential role of Piezo2 in the mediation of visceral sensation.


Subject(s)
Ganglia, Spinal/physiology , Ion Channels/physiology , Touch/physiology , Viscera/physiology , Acetic Acid/administration & dosage , Animals , Animals, Newborn , Colon/drug effects , Colon/physiology , Gene Knockdown Techniques , Ion Channels/genetics , Lumbosacral Region , Male , Nociception/physiology , Physical Stimulation , RNA, Messenger , Rats , Rats, Sprague-Dawley
11.
Cell Physiol Biochem ; 38(3): 1121-8, 2016.
Article in English | MEDLINE | ID: mdl-26963791

ABSTRACT

BACKGROUND/AIMS: In the present study, we describe a novel and straightforward approach to produce a cyclic- arginine-glycine-aspartic (RGD)-peptide-conjugated quantum dot (QD) probe as an ideal target tumor biomarker. Due to its specific structure, the probe can be used for targeted imaging of pancreatic carcinoma cells. METHODS: Pancreatic carcinoma cells were routinely cultured and marked with QD-RGD probe. The QD-RGD probe on the fluorescence-labeled cancer cell was observed by fluorescence microscopy and laser confocal microscopy. Cancer cell viability was detected by MTT assay after culturing with QD-RGD probe. RESULTS: Fluorescence microscopy and laser confocal microscopy displayed that 10nmol/L QD-RGD probe was able to effectively mark pancreatic carcinoma cells. In comparison with organic dyes and fluorescent proteins, the quantum dot-RGD probe had unique optical and electronic properties. CONCLUSION: QD-RGD probe has a low cytotoxicity with an excellent optical property and biocompatibility. These findings support further evaluation of QD-RGD probes for the early detection of pancreatic cancer.


Subject(s)
Fluorescent Dyes/pharmacology , Oligopeptides/pharmacology , Pancreatic Neoplasms/diagnostic imaging , Quantum Dots/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Early Detection of Cancer , Fluorescent Dyes/chemistry , Humans , Microscopy, Confocal , Microscopy, Fluorescence , Pancreatic Neoplasms/pathology , Sensitivity and Specificity , Pancreatic Neoplasms
12.
Intern Med ; 54(3): 251-9, 2015.
Article in English | MEDLINE | ID: mdl-25748732

ABSTRACT

OBJECTIVE: Published data regarding the association between xeroderma pigmentosum group D XPD Lys751Gln polymorphisms and esophageal cancer (EC) cancer remain controversial. The present meta-analysis aimed to obtain a more precise estimation of the relationship between XPD Lys751Gln polymorphisms and the risk of EC. METHODS: All eligible case-control studies of Lys751Gln polymorphisms and susceptibility to EC were selected from PubMed, Web of Science and CNKI up to October 2013. The data were extracted, and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. RESULTS: A total of 21 case-control studies from 19 reports were assessed in this meta-analysis, including 6,581 cases and 8,251 controls. There was a significant association between the XPD Lys751Gln polymorphism and the risk of esophageal cancer in the overall population (Dominant model: OR=1.30, 95%CI: 1.07-1.57, p<0.05; Lys/Gln vs. Gln/Gln: OR=1.20, 95%CI: 1.05-137, p<0.05; Gln/Gln vs. Lys/Lys: OR=1.76, 95%CI: 1.08-2.85, p=0.02; Recessive model: OR=1.48, 95%CI: 1.06-2.07, p=0.02). Similar results were found when stratified according to the cancer type, ethnicity and control source. However, no associations were found among smokers or drinkers. CONCLUSION: The results of this meta-analysis suggest that XPD Lys751Gln polymorphisms contribute to susceptibility to EC.


Subject(s)
Esophageal Neoplasms/genetics , Xeroderma Pigmentosum Group D Protein/genetics , Case-Control Studies , DNA Repair , Esophageal Neoplasms/epidemiology , Genetic Predisposition to Disease , Glutamine , Humans , Lysine , Odds Ratio , Polymorphism, Single Nucleotide , Prognosis , Risk Factors
13.
Tumour Biol ; 36(6): 4519-23, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25596089

ABSTRACT

Gastric cancer (GC) is the fourth most common malignant human cancer. So far, the molecular mechanisms underlying the tumorigenesis of GC are not completely understood. Here, we reported significantly higher levels of serum insulin-like growth factor (IGF)-1 in GC patients and significantly higher levels of phosphorylated IGF-1 receptor (IGF-1R) in the GC specimen. Moreover, IGF-1 induced phosphorylation of IGF-1R and then phosphorylation of its downstream factor Akt in the GC cells. Further, IGF-1/Akt-induced forkhead box protein O1 (FoxO1) nuclear exclusion, but not IGF-1/Akt-induced mTOR phosphorylation, was essential for the augment in GC cell growth. Together, IGF-1/Akt/FoxO1 regulatory machinery appears to be a previously unappreciated signaling axis involved in the carcinogenesis of GC.


Subject(s)
Forkhead Transcription Factors/genetics , Insulin-Like Growth Factor I/biosynthesis , Receptor, IGF Type 1/biosynthesis , Stomach Neoplasms/blood , Carcinogenesis/genetics , Cell Line, Tumor , Cell Proliferation/genetics , Forkhead Box Protein O1 , Forkhead Transcription Factors/antagonists & inhibitors , Forkhead Transcription Factors/biosynthesis , Humans , Insulin-Like Growth Factor I/genetics , Phosphorylation , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Receptor, IGF Type 1/genetics , Signal Transduction/genetics , Stomach Neoplasms/genetics , Stomach Neoplasms/pathology , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism
14.
Mol Med Rep ; 11(4): 2562-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25434307

ABSTRACT

Combination chemotherapy is a crucial method in the treatment of gastric cancer. The aim of the present study was to investigate the inhibitory effects of puerarin and 5­fluorouracil (5­FU) on BGC­823 gastric cancer cells in vitro and in vivo. The in vitro growth inhibition of puerarin or 5­FU alone or combined on BGC­823 cells was determined using a cell counting kit 8 (CCK­8) on living cells. Apoptotic morphological features and proteins expression levels were detected by Hoechst 33258 staining, an Annexin V/propidium iodide apoptosis kit and western blot analysis, respectively. Tumor xenografts were established in nude mice and the inhibitory effects and side effects were detected. Results of the CCK­8, Hoechst 33258 staining and flow cytometry revealed that the combined treatment was more effective than the separate treatments. The tumor volume was 90.65% of that of the controls and the mean tumor weight was only 0.125 g at the end of the experiment in the combination group compared with the control group (0.822 g). In addition, it was determined that liver and renal toxicity did not increase in combined treatment. These findings showed that puerarin and 5­FU produced a significant synergic effect on gastric cancer cells, while there was no increase in side effects.


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Carcinoma/pathology , Fluorouracil/pharmacology , Isoflavones/pharmacology , Stomach Neoplasms/pathology , Animals , Antimetabolites, Antineoplastic/administration & dosage , Apoptosis/drug effects , Carcinoma/drug therapy , Carcinoma/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Disease Models, Animal , Drug Synergism , Fluorouracil/administration & dosage , Humans , Isoflavones/administration & dosage , Male , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Stomach Neoplasms/drug therapy , Stomach Neoplasms/metabolism , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
15.
Int J Clin Exp Med ; 7(9): 2443-52, 2014.
Article in English | MEDLINE | ID: mdl-25356096

ABSTRACT

BACKGROUND: Although xeroderma pigmentosum group D (XPD) was reported to be related with esophageal cancer (EC) risk, the results remained inconsistent. The aim of this meta-analysis was to make a more precise estimation of the relationship between XPD Asp312Asn polymorphism and EC risk. METHODS: We searched PubMed, Web of Science, Embase, Medline, CNKI and Chinese Biomedical database, covering all publications (up to May, 2014). Statistical analyses were performed with Stata software (version 12.0, USA) and RevMan 5.1 (Copenhagen, 2008). The calculation of odds ratios (ORs) with 95% confidence intervals (CI) was calculated to assess the strength of the association. RESULTS: A total of 15 case-control studies from 13 literatures including 3928 cases and 6012 controls described Asp312Asn genotypes and EC risk. A significant association between XPD Asp312Asn polymorphism and EC risk was found when all the eligible studies were pooled into this meta-analysis. It's also the same result in subgroup analysis of smokers in dominant model (OR=1.63, 95% CI: 1.06-2.50, P=0.03). However, in the stratified analysis by ethnicity and source of population controls, no association between them was discovered. CONCLUSION: The XPD Asp312Asn polymorphism was proved to contribute to the risk of EC in this meta-analysis. Data showed that tobacco consumption may increase the susceptibility of EC.

16.
Cell Biochem Biophys ; 69(3): 619-25, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24522517

ABSTRACT

Myc-induced nuclear antigen (Mina53) is a protein with a molecular weight of 53 kDa expression of which is induced by c-Myc. Increased expression of Mina53 is documented in some human carcinomas. In this study, we found markedly increased Mina53 expression in pancreatic cancer tissue specimens. This expression did not correlate with clinicopathological characteristics, such as sex, age, and presence of distant metastasis. However, there was a statistically significant association with histological differentiation, TNM stage, and lymph node metastases. To study functional role of Mina53, we silenced its expression by siRNA in PANC-1 cells. These cells were arrested in the G2/M phase, and apoptosis rates were increased. In conclusion, increased expression of Mina53 may play an important role in the development of human pancreatic cancer. Mina53 can be used as a marker for pancreatic cancer and may potentially be exploited as a target for treatment of pancreatic cancer.


Subject(s)
Nuclear Proteins/metabolism , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , Apoptosis/genetics , Biomarkers, Tumor/deficiency , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Cell Line, Tumor , Cell Proliferation/genetics , Dioxygenases , Female , Gene Expression Regulation, Neoplastic , Histone Demethylases , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Nuclear Proteins/deficiency , Nuclear Proteins/genetics , Pancreatic Neoplasms/genetics , RNA Interference , RNA, Small Interfering/genetics
17.
Oncol Lett ; 5(6): 1844-1848, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23833653

ABSTRACT

Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) is a postsynaptic density-95/disc-large/zonula occludens-1 (PDZ) homologous domain-containing protein that is involved in cell signaling. EBP50 regulates cell apoptosis, proliferation and invasion. In the present study, the prognostic impact factor of EBP50 expression was evaluated using a quantum dot (QD)-based assay and immunohistochemistry (IHC). The EBP50 protein expression in gastric cancer (GC) tissues was evaluated using IHC and QD-IHC. The study included 101 patients with GC (29 females and 72 males, aged 24-81 years), diagnosed and treated at the General Surgery Department of Renmin Hospital of Wuhan University (Wuhan, China) between 2000 and 2005. The survival rate was calculated using the Kaplan-Meier method and log-rank tests. IHC and QD analyses of 101 GC tissue specimens revealed that EBP50-positive tumor cells were frequently present in GC. Increased EBP50 immunostaining was observed in 63 specimens (62.4%). The EBP50 expression levels were correlated with increased tumor size and the male gender. EBP50 was well distributed in the cytoplasm and nuclei of the GC cells. However, EBP50 protein expression exhibited no correlation with age, differentiation, stage or lymph node metastasis. There were no associations between the expression of EBP50 and the mean survival rates (IHC, 50.5 vs. 58.1 months, P>0.05; QD, 55.4 vs. 63.2 months, P>0.05). These findings suggest that EBP50 protein expression is not correlated with the prognosis of patients with GC. QD-IHC and IHC have similar advantages for the detection of EBP50 protein expression.

18.
J Mol Histol ; 43(5): 517-26, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22622406

ABSTRACT

Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) is a putative tumor suppressor that is correlated with many human cancers. However, the function of EBP50 in pancreatic cancer (PC) has not been described. In this paper, the EBP50 expression level in PC tissues was characterized. In vitro, the effects of EBP50 down-regulation by siRNA in PC-2 and MiaPaCa-2 cells were evaluated. In addition, possible mechanisms that mediate the influence of EBP50 were examined. Our results show that the EBP50 expression pattern changes during transformation as there is a loss of the normal apical membrane distribution and an ectopic cytoplasmic over-expression of EBP50; furthermore, the EBP50 expression level is subsequently decreased during malignant progression. Down-regulation of EBP50 promoted cancer cell proliferation, increased the colony-forming ability of cells and accelerated the G1-to-S progression. Additionally, the loss of EBP50 accentuated ß-catenin activity, increased cyclin E and phosphorylated Rb expression, and attenuated p27 expression compared to control cells. Our results suggest that EBP50 may function as a potential tumor suppressor.


Subject(s)
Cell Proliferation , Cell Transformation, Neoplastic/metabolism , Pancreatic Neoplasms , Phosphoproteins , Sodium-Hydrogen Exchangers , Cell Line, Tumor , Cyclin E/metabolism , Gene Expression Regulation, Neoplastic , Humans , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , Phosphoproteins/genetics , Phosphoproteins/metabolism , Proliferating Cell Nuclear Antigen/metabolism , Quantum Dots , RNA, Small Interfering , Sodium-Hydrogen Exchangers/genetics , Sodium-Hydrogen Exchangers/metabolism , beta Catenin/metabolism
19.
Biochem Biophys Res Commun ; 421(3): 627-33, 2012 May 11.
Article in English | MEDLINE | ID: mdl-22546556

ABSTRACT

Noscapine, a phthalide isoquinoline alkaloid derived from opium, has been widely used as a cough suppressant for decades. Noscapine has recently been shown to potentiate the anti-cancer effects of several therapies by inducing apoptosis in various malignant cells without any detectable toxicity in cells or tissues. However, the mechanism by which noscapine induces apoptosis in colon cancer cells remains unclear. The signaling pathways by which noscapine induces apoptosis were investigated in colon cancer cell lines treated with various noscapine concentrations for 72 h, and a dose-dependent inhibition of cell viability was observed. Noscapine effectively inhibited the proliferation of LoVo cells in vitro (IC(50)=75 µM). This cytotoxicity was reflected by cell cycle arrest at G(2)/M and subsequent apoptosis, as indicated by increased chromatin condensation and fragmentation, the upregulation of Bax and cytochrome c (Cyt-c), the downregulation of survivin and Bcl-2, and the activation of caspase-3 and caspase-9. Moreover, in a xenograft tumor model in mice, noscapine injection clearly inhibited tumor growth via the induction of apoptosis, which was demonstrated using a TUNEL assay. These results suggest that noscapine induces apoptosis in colon cancer cells via mitochondrial pathways. Noscapine may be a safe and effective chemotherapeutic agent for the treatment of human colon cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Colonic Neoplasms/drug therapy , Mitochondria/drug effects , Noscapine/pharmacology , Animals , Antineoplastic Agents/therapeutic use , Caspase 3/metabolism , Caspase 9/metabolism , Cell Cycle Checkpoints , Cell Line, Tumor , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cytochromes c/metabolism , Humans , Male , Mice , Mice, Inbred BALB C , Noscapine/therapeutic use , Xenograft Model Antitumor Assays , bcl-2-Associated X Protein/metabolism
20.
World J Gastroenterol ; 18(14): 1590-601, 2012 Apr 14.
Article in English | MEDLINE | ID: mdl-22529687

ABSTRACT

AIM: To investigate the mechanisms of the biological roles of Dickkopf-3 (Dkk-3) in cell invasion, survival and apoptosis in colon cancer cells. METHODS: Three human colon cancer cell lines, i.e., HT-29, LoVo and SW480, were used. Overexpression of Dkk-3 induced by pEGFP-N1-Dkk-3-GFP plasmid in LoVo cells was performed using Lipofectamine 2000 reagent. Reverse transcription polymerase chain reaction and Western blotting were performed to determine the mRNA and protein expression levels of Dkk-3, respectively. Cell proliferation assay, cell cycle analysis, hoechst 33258 assay and Matrigel invasion assay were performed on Dkk-3 overexpressing transfectants. RESULTS: The mRNA and protein expressions of Dkk-3 in HT-29 (mRNA: 0.06 ± 0.02, protein: 0.06 ± 0.01) and LoVo (mRNA: 0.07 ± 0.02, protein: 0.07 ± 0.02) cells were significantly lower than that in SW480 cells (mRNA: 0.92 ± 0.04, protein: 0.69 ± 0.13; all P < 0.05), and the greatest levels of invasiveness was in LoVo cells. Dkk-3 overexpression inhibited the proliferation and invasion of LoVo cells and induced cell cycle arrest at G(0)/G(1) phase and subsequent apoptosis, as indicated by increased chromatin condensation and fragments, upregulated Bax and cytochrome c protein, downregulated survivin and Bcl-2 protein, and the activation of caspase-3 and caspase-9. Furthermore, Dkk-3 overexpression reduced the accumulation of cytosolic fraction of ß-catenin. CONCLUSION: Dkk-3 overexpression induced apoptosis in human colon cancer possibly through the mitochondrial pathway. Dkk-3 may be involved in the Wnt/ß-catenin signaling pathways in colon cancer.


Subject(s)
Adenocarcinoma/metabolism , Apoptosis/physiology , Colonic Neoplasms/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Mitochondria/metabolism , RNA, Messenger/analysis , Adaptor Proteins, Signal Transducing , Cell Line, Tumor , Cell Proliferation , Chemokines , G1 Phase Cell Cycle Checkpoints/physiology , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , HT29 Cells , Humans , Wnt Signaling Pathway/physiology , beta Catenin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...